Parkinsonism genes: Culprits and clues

Journal of Neurochemistry

Volumn 99, Issue 4, 2006, Pages 1062-1072

  Abeliovich, Asa ^a   Flint Beal, M ^b  

^a College of Physicians and Surgeons 15 403 ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

DJ 1; LRRK2 Synuclein; Parkin; Parkinson's disease; PINK1

Indexed keywords

ALPHA SYNUCLEIN; CYTOPLASM PROTEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN PINK1; RAS PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

DOPAMINERGIC NERVE CELL; FAMILIAL DISEASE; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

ALPHA-SYNUCLEIN; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 33750459730     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04102.x     Document Type: Review

References (118)

1. Abeliovich A., Schmitz. Y., Farinas I. et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.
2. Abysalh J. C., Kuchnicki L. L. and Larochelle D. A. (2003) The identification of pats1, a novel gene locus required for cytokinesis in Dictyostelium discoideum. Mol Biol. Cell 14, 14-25.
3. Beal M. F. (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N Y Acad. Sci. 991, 120-131.
4. Betarbet R., Sherer T. B., Di Monte D. A. and Greenamyre J. T. (2002) Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol 12, 499-510.
5. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 3, 1301-1306.
6. Bonifati V., Rizzu P., van Baren M. J. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259.
7. Bosco D. A., Fowler D. M., Zhang Q., Nieva J., Powers E. T., Wentworth P., Lerner R. A. and Kelly J. W. (2006) Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem. Biol. 2, 249-253.
8. Bosgraaf L. and Van Haastert P. J. (2003) Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 1643, 5-10.
9. Cabin D. E., Shimazu K., Murphy D. et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797-8807.
10. Canet-Aviles R. M., Wilson M. A., Miller D. W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M. J., Ringe D., Petsko G. A. and Cookson M. R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. U S A 101, 9103-9108.
11. Cha G. H., Kim S., Park J., Lee E., Kim M., Lee S. B., Kim J. M., Chung J. and Cho K. S. (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc. Natl Acad. Sci. U S A 102, 10 345-10 350.
12. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O. M. and Sudhof T. C. (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383-396.
13. Chung K. K., Zhang Y., Lim K. L., Tanaka Y., Huang H., Gao J., Ross C. A., Dawson V. L. and Dawson T. M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin- 1: implications for Lewy-body formation in Parkinson disease. Nat Med. 7, 1144-1150.
14. Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A. and Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature.
15. von Coelln R., Thomas B., Andrabi S. A. et al. (2006) Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy. J. Neurosci. 26, 3685-3696.
16. Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Williamson R. E. and Lansbury P. T. Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. U S A 97, 571-576.
17. Cooper A. A., Gitler A. D., Cashikar A. et al. (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328.
18. Cuervo A. M., Stefanis L., Fredenburg R., Lansbury P. T. and Sulzer D. (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295.
19. Darios F., Corti O., Lucking C. B. et al. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526.
20. Datta S. R., Brunet A. and Greenberg M. E. (1999) Cellular survival: a play in three Akts. Genes Dev 13, 2905-2927.
21. Davies H., Bignell G. R., Cox C. et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
22. Di Fonzo A., Rohe C. F., Ferreira J. et al. (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365, 412-415.
23. Feany M. B. and Bender W. W. (2000) A Drosophila model of Parkinson's disease. Nature 404, 394-398.
24. Fortin D. L., Nemani V. M., Voglmaier S. M., Anthony M. D., Ryan T. A. and Edwards R. H. (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 25, 10 913-10 921.
25. Galter D., Westerlund M., Carmine A., Lindqvist E., Sydow O. and Olson L. (2006) LRRK2 expression linked to dopamine-innervated areas. Ann. Neurol. 59, 714-719.
26. Galvin J. E., Uryu K., Lee V. M. and Trojanowski J. Q. (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl Acad. Sci. U S A 96, 13 450-13 455.
27. Gelb D. J., Oliver E. and Gilman S. (1999) Diagnostic criteria for Parkinson disease. Arch. Neurol. 56, 33-39.
28. Giasson B. I., Duda J. E., Quinn S. M., Zhang B., Trojanowski J. Q. and Lee V. M. (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34, 521-533.
29. Giasson B. I., Forman M. S., Higuchi M., Golbe L. I., Graves C. L., Kotzbauer P. T., Trojanowski J. Q. and Lee V. M. (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636-640.
30. Gilks W. P., Abou-Sleiman P. M., Gandhi S. et al. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 356, 415-416.
31. Gispert S., Del Turco D., Garrett L. et al. (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci. 24, 419-429.
32. Gloeckner C. J., Kinkl N., Schumacher A., Braun R. J., O'Neill E., Meitinger T., Kolch W., Prokisch H. and Ueffing M. (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 15, 223-232.
33. Goedert M., Crowther R. A. and Spillantini M. G. (1998) Tau mutations cause frontotemporal dementias. Neuron 21, 955-958.
34. Goldberg M. S., Fleming S. M., Palacino J. J. et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43 628-43 635.
35. Goldberg M. S., Pisani A., Haburcak M. et al. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45, 489-496.
36. Greene J. C., Whitworth A. J., Kuo I., Andrews L. A., Feany M. B. and Pallanck L. J. (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. U S A 100, 4078-4083.
37. Greggio E., Jain S., Kingsbury A. et al. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 23, 329-341.
38. Hashimoto M., Hsu L. J., Sisk A., Xia Y., Takeda A., Sundsmo M. and Masliah E. (1998) Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 799, 301-306.
39. Hershko A. and Ciechanover A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
40. Hod Y., Pentyala S. N., Whyard T. C. and El-Maghrabi M. R. (1999) Identification and characterization of a novel protein that regulates RNA-protein interaction. J. Cell Biochem. 72, 435-444.
41. Huynh D. P., Scoles D. R., Nguyen D. and Pulst S. M. (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet 12, 2587-2597.
42. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K. I. and Takahashi R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 10, 55-67.
43. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y. and Takahashi R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902.
44. Imai Y., Soda M. and Takahashi R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275, 35 661-35 664.
45. Itier J. M., Ibanez. P., Mena M. A. et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12, 2277-2291.
46. Jiang H., Ren Y., Zhao J. and Feng J. (2004) Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet 13, 1745-1754.
47. Kahle P. J., Neumann M., Ozmen L. et al. (2001) Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am. J. Pathol 159, 2215-2225.
48. Kim R. H., Smith P. D., Aleyasin H. et al. (2005a) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl Acad. Sci. U S A 102, 5215-5220.
49. Kim R. H., Peters M., Jang Y. et al. (2005b) DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263-273.
50. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y. and Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.
51. Ko H. S., Kim S. W., Sriram S. R., Dawson V. L. and Dawson T. M. (2006) Identification of far up stream element binding protein-1 as an authentic parkin substrate. J Biol Chem.
52. Ko H. S., von Coelln R., Sriram S. R. et al. (2005) Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci. 25, 7968-7978.
53. Kuroda Y., Mitsui T., Kunishige M., Shono M., Akaike M., Azuma H. and Matsumoto T. (2006) Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 15, 883-895.
54. Langston J. W., Langston E. B. and Irwin I. (1984) MPTP-induced parkinsonism in human and non-human primates - clinical and experimental aspects. Acta Neurol. Scandsupplement 100, 49-54.
55. Lashuel H. A., Petre B. M., Wall J., Simon M., Nowak R. J., Walz. T. and Lansbury P. T. Jr (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol Biol. 322, 1089-1102.
56. Lee V. M., Goedert M. and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
57. Lee M. K., Stirling W., Xu Y., Xu X., Qui D., Mandir A. S., Dawson T. M., Copeland N. G., Jenkins N. A. and Price D. L. (2002) Human alpha-synuclein- harboring familial Parkinson's disease-linked Ala-53 - > Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci. U S A 99, 8968-8973.
58. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A. L., Janin S., Pollak P. and Brice A. (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354, 422-423.
59. Martin L. J., Pan Y., Price A. C., Sterling W., Copeland N. G., Jenkins N. A., Price D. L. and Lee M. K. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41-50.
60. Martin E. R., Scott W. K., Nance M. A. et al. (2001) Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. Jama 286, 2245-2250.
61. Martinat C., Shendelman S., Jonason A., Leete T., Beal M. F., Yang L., Floss T. and Abeliovich A. (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary parkinsonism. PLoS Biol 2, e327.
62. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
63. Melrose H., Lincoln S., Tyndall G., Dickson D. and Farrer M. (2006) Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience.
64. Menzies F. M., Yenisetti S. C. and Min K. T. (2005) Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr. Biol. 15, 1578-1582.
65. Meulener M. C., Graves C. L., Sampathu D. M., Armstrong-Gold C. E., Bonini N. M. and Giasson B. I. (2005b) DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein. J. Neurochem. 93, 1524-1532.
66. Meulener M., Whitworth A. J., Armstrong-Gold C. E., Rizzu P., Heutink P., Wes P. D., Pallanck L. J. and Bonini N. M. (2005a) Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 15, 1572-1577.
67. Miller D. W., Hague S. M., Clarimon J., Baptista M., Gwinn-Hardy K., Cookson M. R. and Singleton A. B. (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62, 1835-1838.
68. Mitsumoto A., Nakagawa Y., Takeuchi A., Okawa K., Iwamatsu A. and Takanezawa Y. (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res. 35, 301-310.
69. Mizuno Y., Hattori N. and Mori H. (1999) Genetics of Parkinson's disease. Biomed Pharmacother 53, 109-116.
70. Moore D. J., Zhang L., Troncoso J., Lee M. K., Hattori N., Mizuno Y., Dawson T. M. and Dawson V. L. (2005) Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 14, 71-84.
71. Nichols W. C., Pankratz N., Hernandez D. et al. (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet, 365, 410-412.
72. Norris E. H. and Giasson B. I. (2005) Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders. Antioxid Redox Signal 7, 672-684.
73. Olzmann J. A., Brown K., Wilkinson K. D., Rees H. D., Huai Q., Ke H., Levey A. I., Li L. and Chin L. S. (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J. Biol. Chem. 279, 8506-8515.
74. Outeiro T. F. and Lindquist S. (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772-1775.
75. Ozelius L. J., Senthil G., Saunders-Pullman R. et al. (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354, 424-425.
76. Paisan-Ruiz. C., Jain S., Evans E. W. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600.
77. Palacino J. J., Sagi D., Goldberg M. S., Krauss S., Motz. C., Wacker M., Klose J. and Shen J. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279, 18 614-18 622.
78. Park J., Kim S. Y., Cha G. H., Lee S. B., Kim S. and Chung J. (2005) Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361, 133-139.
79. Park J., Lee S. B., Lee S. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature.
80. PereZ. F. A. and Palmiter R. D. (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl Acad. Sci. U S A 102, 2174-2179.
81. Pesah Y., Pham T., Burgess H., Middlebrooks B., Verstreken P., Zhou Y., Harding M., Bellen H. and Mardon G. (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131, 2183-2194.
82. Petrucelli L., O'Farrell C., Lockhart P. J. et al. (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36, 1007-1019.
83. Polymeropoulos M. H. (2000) Genetics of Parkinson's disease. Ann. N Y Acad. Sci. 920, 28-32.
84. Rochet J. C., Conway K. A. and Lansbury P. T. Jr (2000) Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry 39, 10 619-10 626.
85. Shendelman S., Jonason A., Martinat C., Leete T. and Abeliovich A. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2, e362.
86. Shimura H., Hattori N., Kubo S. et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25, 302-305.
87. Shimura H., Schlossmacher M. G., Hattori N., Frosch M. P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K. S. and Selkoe D. J. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269.
88. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E. M. and Casari G. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14, 3477-3492.
89. Singleton A. B. (2005) Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin. Trends Neurosci. 28, 416-421.
90. Singleton A. B., Farrer M., Johnson J. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
91. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
92. Staropoli J. F., McDermott C., Martinat C., Schulman B., Demireva E. and Abeliovich A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735-749.
93. Stefanis L., Larsen K. E., Rideout H. J., Sulzer D. and Greene L. A. (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 21, 9549-9560.
94. Taira T., Saito Y., Niki T., Iguchi-Ariga S. M., Takahashi K. and Ariga H. (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5, 213-218.
95. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S. M. and Ariga H. (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276, 37 556-37 563.
96. Tanaka Y., Engelender S., Igarashi S., Rao R. K., Wanner T., Tanzi R. E., Sawa A. V. L. D., Dawson T. M. and Ross C. A. (2001) Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 10, 919-926.
97. Tang B., Xiong H., Sun P. et al. (2006) Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet 15, 1816-1825.
98. Trojanowski J. Q., Schmidt M. L., Shin R. W., Bramblett G. T., Rao D. and Lee V. M. (1993) Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol 3, 45-54.
99. Unoki M. and Nakamura Y. (2001) Growth-suppressive effects of BPOZ. and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20, 4457-4465.
100. Valente E. M., Salvi S., Ialongo T., Marongiu R., Elia A. E., Caputo V., Romito L., Albanese A., Dallapiccola B. and Bentivoglio A. R. (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 56, 336-341.
101. Von Coelln R., Thomas B., Savitt J. M., Lim K. L., Sasaki M., Hess E. J., Dawson V. L. and Dawson T. M. (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc. Natl Acad. Sci. U S A 101, 10 744-10 749.
102. Weinreb P. H., Zhen W., Poon A. W., Conway K. A. and Lansbury P. T. Jr (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13 709-13 715.
103. West A. B., Moore D. J., Biskup S., Bugayenko A., Smith W. W., Ross C. A., Dawson V. L. and Dawson T. M. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. U S A 102, 16842-16847.
104. Whitworth A. J., Theodore D. A., Greene J. C., Benes H., Wes P. D. and Pallanck L. J. (2005) Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc. Natl Acad. Sci. U S A 102, 8024-8029.
105. Willems A. R., Goh T., Taylor L., Chernushevich I., Shevchenko A. and Tyers M. (1999) SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 1533-1550.
106. Willesen M. G., Gammeltoft S. and Vaudano E. (2002) Activation of the c-Jun N terminal kinase pathway in an animal model of Parkinson's disease. Ann. N Y Acad. Sci. 973, 237-240.
107. Wilson M. A., Ringe D. and Petsko G. A. (2005) The atomic resolution crystal structure of the YajL (ThiJ) protein from Escherichia coli: a close prokaryotic homologue of the Parkinsonism-associated protein DJ-1. J Mol Biol 353, 678-691.
108. Wszolek Z. K., Pfeiffer R. F., Tsuboi Y. et al. (2004) Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62, 1619-1622.
109. Xu J., Kao S. Y., Lee F. J., Song W., Jin L. W. and Yankner B. A. (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med. 8, 600-606.
110. Xu J., Zhong N.,Wang H., Elias J. E., Kim C.Y.,Woldman I., Pifl C., Gygi S. P., Geula C. and Yankner B. A. (2005) The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet 14, 1231-1241.
111. Yang Y., Gehrke S., Haque M. E. et al. (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl Acad. Sci. USA 102, 13 670-13 675.
112. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J., Yang L., Beal M. F., Vogel H. and Lu B. (2006) Muscle and dopaminergic degeneration caused by inactivation of Drosophila Pten-induced kinase1 (Pink1) is suppressed by Parkproceedings of the Natl Acad. Sci. U S A.
113. Yoshiyama Y., Lee V. M. and Trojanowski J. Q. (2001) Frontotemporal dementia and tauopathy. Curr. Neurol. Neurosci. Rep 1, 413-421.
114. Zhang Y., Gao J., Chung K. K., Huang H., Dawson V. L. and Dawson T. M. (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. U S A 97, 13 354-13 359.
115. Zhang L., Shimoji M., Thomas B. et al. (2005) Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14, 2063-2073.
116. Zhou W. and Freed C. R. (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 280, 43 150-43 158.
117. Zhou W., Zhu M., Wilson M. A., Petsko G. A. and Fink A. L. (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J. Mol Biol. 356, 1036-1048.
118. Zimprich A., Biskup S., Leitner P. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607.